1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Croatia Pharmaceuticals and Healthcare Report Q2 2016

Croatia Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 77 pages

Includes 3 FREE quarterly updates

BMI View: Continued political instability coupled with a bleak economic outlook will continue to repressthe pharmaceutical and healthcare sectors in Croatia. Necessary austerity measures will impose furtherbarriers towards growth and reduce the use of high-value patented drugs, highlighting minimal revenueearning opportunities for multinational pharmaceutical firms.

Headline Expenditure Projections

- Pharmaceuticals: HRK6.73bn (USD961mn) in 2015 to HRK6.76bn (USD931mn) in 2016; 0.5% inlocal currency and -3.2% in US dollar terms. Forecast revised upwards compared with Q116.

- Healthcare: HRK21.99bn (USD3.14bn) in 2015 to HRK21.66bn (USD2.99bn) in 2016; -1.5% in localcurrency and -5.1% in US dollar terms. Forecast revised slightly upwards compared with Q116.

Table Of Contents

Croatia Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Croatia 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Croatia 2012-2020) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Croatia 2012-2020) 16
Prescription Drug Market 17
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Croatia 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Croatia 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Croatia 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Croatia 2014-2020) 27
Industry Risk Reward Index 28
Central And Eastern Europe Risk/Reward Index 28
Croatia Risk/Reward Index 34
Rewards 34
Risks 35
Regulatory Review 36
Intellectual Property Issues 38
Pricing Regime 38
Table: New Profit Margins For Wholesalers 40
Reimbursement Regime 40
Risk Sharing Schemes 42
Pharmaceutical Cost-Effectiveness Measures 42
OTC Regulations 42
Generic Regulations 43
Biosimilars 43
Market Overview 44
Healthcare Sector 45
Table: Healthcare Resources (Croatia 2010-2015) 45
Table: Healthcare Personnel (Croatia 2010-2015) 45
Table: Healthcare Activity (Croatia 2010-2015) 46
Table: Reimbursed Drug Expenditure By HZZO (HRKbn) - Equivalent To Final Consumer Prices 47
Research and Development 48
Clinical Trials 49
Epidemiology 50
Table: Cancer Incidence Rates, 2010-2035 52
Competitive Landscape 54
Research-Based Industry 54
Table: Multinational Market Activity 55
Generic Drugmakers 56
Pharmaceutical Distribution 56
Pharmaceutical Retail 57
Company Profile 58
Belupo 58
Jadran Galenski Laboratorij 61
PLIVA 63
Demographic Forecast 66
Table: Population Headline Indicators (Croatia 1990-2025) 67
Table: Key Population Ratios (Croatia 1990-2025) 67
Table: Urban/Rural Population and Life Expectancy (Croatia 1990-2025) 68
Table: Population By Age Group (Croatia 1990-2025) 68
Table: Population By Age Group % (Croatia 1990-2025) 69
Glossary 71
Methodology 73
Pharmaceutical Expenditure Forecast Model 73
Healthcare Expenditure Forecast Model 73
Notes On Methodology 74
Risk/Reward Index Methodology 75
Index Overview 76
Table: Pharmaceutical Risk/Reward Index Indicators 76
Indicator Weightings 77

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.